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Abstract
Background: Plasmodium falciparum STEVOR proteins, encoded by the multicopy stevor gene
family have no known biological functions. Their expression and unique locations in different
parasite life cycle stages evoke multiple functionalities. Their abundance and hypervariability
support a role in antigenic variation.
Methods: Immunoblotting of total parasite proteins with an anti-STEVOR antibody was used to
identify variant antigens of this gene family and to follow changes in STEVOR expression in parasite
populations panned on CSA or CD36 receptors. Immunofluorescence assays and immunoelectron
microscopy were performed to study the subcellular localization of STEVOR proteins in different
parasite stages. The capacity of the antibody to inhibit merozoite invasion of erythrocytes was
assessed to determine whether STEVOR variants were involved in the invasion process.
Results:  Antigenic variation of STEVORs at the protein level was observed in blood stage
parasites. STEVOR variants were found to be present on the merozoite surface and in rhoptries.
An insight into a participation in erythrocyte invasion was gained through an immunofluorescence
analysis of a sequence of thin slides representing progressive steps in erythrocyte invasion. An
interesting feature of the staining pattern was what appeared to be the release of STEVORs around
the invading merozoites. Because the anti-STEVOR antibody did not inhibit invasion, the role of
STEVORs in this process remains unknown.
Conclusion: The localization of STEVOR proteins to the merozoite surface and the rhoptries
together with its prevalence as a released component in the invading merozoite suggest a role of
these antigens in adhesion and/or immune evasion in the erythrocyte invasion process. These
observations would also justify STEVORs for undergoing antigenic variation. Even though a role in
erythrocyte invasion remains speculative, an association of members of the STEVOR protein family
with invasion-related events has been shown.
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Background
Of the four species causing human malaria, Plasmodium
falciparum is the most fatal aetiologic agent. Its ability to
invade erythrocytes of all ages leads to high blood levels
of parasitaemia. It exports proteins to the erythrocyte sur-
face, facilitating cytoadherence to endothelial receptors
and microvascular sequestration, thereby causing abnor-
mal function of the affected tissues [1].
The multicopy var gene family encoding variant surface
antigens known as P. falciparum erythrocyte membrane
protein 1 (PfEMP1) is the best characterized exported pro-
tein that undergoes antigenic variation (reviewed in [2]).
Other variant antigens with speculated roles in antigenic
variation also belong to multigene families, namely the rif
(repetitive interspersed family), stevor (subtelomeric vari-
able open reading frame) and Pfmc-2TM multicopy gene
families [3]. In carrying a signal peptide and a Pexel/VTS
motif (Plasmodium export element/vacuolar transport sig-
nal) [4,5], these proteins are potentially exported to the
host cytoplasm and membrane. The presence of a hyper-
variable loop domain flanked by two predicted trans-
membrane domains is also suggestive of surface exposure.
Expression of antigenically distinct RIFIN variants in dif-
ferent parasite strains and life cycle stages was recently
observed [6]. Transcription studies demonstrated that the
expression of stevor and Pfmc-2TM gene families is clon-
ally variant and undergoes switching [7], but confirma-
tion of antigenic variation at the protein level is lacking.
STEVORs are reported in sporozoites and gametocytes [8],
and in Maurer's clefts (MC) of trophozoites and schizonts
[9]. MC are flattened vesicular structures beneath the
infected erythrocyte (IE) membrane and may translocate
parasite proteins to the erythrocyte surface [10]. Because
of their expression and unique location in different para-
site stages, these proteins probably have multiple func-
tions.
The Plasmodium parasite undergoes three invasive stages
during its life cycle. Invasion of erythrocytes by mero-
zoites in iterative cycles causes the clinical manifestations
of the disease, including fever, anaemia and coma [11].
Merozoite proteins are thus considered vaccination tar-
gets, and strategies include blocking maturation of infec-
tive merozoites, exit from host erythrocytes, and invasion
of new erythrocytes. Synthetic 20-mer peptides from one
STEVOR protein and antibodies thereof were shown to
inhibit merozoite invasion of erythrocytes [12].
Here, STEVOR proteins were identified in merozoites and
protein release during erythrocyte invasion was demon-
strated. Implication of multicopy variant antigens in inva-
sion adds to the complexity of the process and opens up
new avenues for research on blocking the malarial life
cycle.
Methods
Parasite strains and culture
The Plasmodium falciparum strains used in this study were
NF54 and Gb337 [13]. The strains were cultured in O+
human erythrocytes at 5% haematocrit in RPMI-1640
medium supplemented with 0.5% Albumax II (Gibco,
Carlsbad, CA, USA), 2% human AB serum (PAA,
Pasching, Austria), 200 μM hypoxanthine (Sigma, St.
Louis, MO, USA) and 20 μg/mL gentamycin (Gibco).
Enrichment of CSA and CD36 phenotypes
The NF54CSA and NF54CD36 parasite phenotypes were gen-
erated by the selection of chondroitin sulfate A (CSA) and
CD36 binding NF54 parasites on immobilized CSA and
C32 melanoma cells, respectively. The resulting parasite
phenotypes were used via immunoblotting to examine
the effect of parasite selection and phenotypic changes on
levels of STEVOR expression and STEVOR variant types.
Lysed infected erythrocytes preparation and 
immunoblotting
Erythrocytes infected with P. falciparum ring stages were
synchronized twice, 4 h apart, by sorbitol treatment
(Sigma, St. Louis, MO, USA) [14] and grown to high par-
asitaemia (≈ 10%) of mostly late trophozoite stages. Late-
stage IE were enriched to a parasitaemia of about 90 –
95% by magnet-activated cell sorting (MACS). Enriched
IE were resuspended in 500 μl PBS, counted, lysed by the
addition of saponin to a final concentration of 0.15% and
kept on ice for 15 min. Lysed IE were collected by centrif-
ugation for 5 min at 13,000 rpm at 4°C, the pellet was
washed twice in PBS followed by centrifugation and the
proteins from the final pellet were extracted by boiling in
1 × SDS sample buffer for 10 min. A fraction of the protein
extract equivalent to 3 × 107 IE/lane was loaded onto SDS-
polyacrylamide gels and separated proteins were trans-
ferred to Trans-Blot transfer medium membrane (Bio-
Rad, Hercules, CA, USA). Equal loading was also con-
firmed by Ponceau S staining. The membrane was probed
with mouse anti-STEVOR antibodies, as previously
described [15], namely anti-PFA0750w, -PFL2610w, -
MAL13P1.7 or -PFC0025c (each at 1:3000). These anti-
bodies were previously incubated with unrelated His-
fusion protein blotted to membranes to absorb out the
anti-His antibodies. Reactivity was visualized by goat anti-
mouse IgG coupled to horseradish peroxidase (1:30 000;
Pierce, Rockford, IL, USA). Blots were developed by the
enhanced chemiluminescent (ECL Western blot analysis
system)-based detection according to manufacturer's
instructions (GE Healthcare, Life Sciences, Bucks, UK).Malaria Journal 2008, 7:137 http://www.malariajournal.com/content/7/1/137
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Immunofluorescence assays and co-localization
For indirect IFA, parasites were cultured and synchronized
as described above and allowed to grow for one cycle
before samples were processed. IE representing the ring,
trophozoite and schizont stages were smeared on glass
slides, air-dried and fixed for 5 min with ice cold 100%
methanol. Gametocyte stage parasites were prepared as
previously described [16] with the slight modification
that no N-acetyl-D-glucosamine was added and fixed as
described above. Slides from different stages were incu-
bated at room temperature for 2 h with mouse anti-STE-
VOR antibodies (1:500) or a mix of mouse anti-STEVOR
antibodies (1:500) and rabbit anti-MSP1 antibody
(1:200). Binding of the primary antibodies was visualized
by Alexa 488-conjugated goat anti-mouse (1:1000; Molec-
ular Probes) when anti-STEVOR antibodies were solely
used, whereas a mixture of Alexa 594-conjugated goat
anti-mouse (1:400; Molecular Probes) and Cy2-conju-
gated goat anti-rabbit antibodies (1:400; Dianova, Ham-
burg, Germany) were used when combining the analysis
of both anti-STEVOR and anti-MSP1 primary antibodies.
Cell nuclei were visualized by DAPI (4',6-diamidino-2-
phenylindole) (5 μg/ml; Roth, Germany). Slides were
mounted on MOWIOL (Calbiochem, San Diego, CA,
USA), viewed and captured using a Leica fluorescence
microscope with the help of OpenLab software. Pre-
immune sera were used to replace the corresponding anti-
STEVOR antibodies for the negative control slides.
Immunoelectron microscopy
Late stage parasites were enriched by MACS and fixed
using a mixture of 1% paraformaldehyde and 0.025% glu-
taraldehyde in cacodylate buffer for 1 h at 4°C, embedded
in LR white resin with the accelerator (London Resin
Company, London, UK) and sectioned with a Reichert
Ultracut E microtome (Leica, Germany). Ultrathin sec-
tions were incubated for 15 min in PBS, blocked for 1 h at
room temperature using PBS/BSA (10%) and incubated
with anti-STEVOR antibody (anti-PFL2610w) (1:10 000)
for 1 h at 37°C and overnight at 4°C. After four washes
with PBS/BSA, the sections were incubated with rat anti-
mouse antibody (1:5000, Dianova, Hamburg, Germany)
for 45 min at 20°C. Sections were washed four times with
PBS/BSA and were treated with gold (10 nM) conjugated
Protein A (Department of Cell Biology, School of Medi-
cine, University of Utrecht, NL) at a dilution of 1:70 for 45
min at 20°C. Thereafter, sections were washed five times
using PBS and stained with 2% uranyl acetate for 5 min
and Reynolds lead citrate for 1 min for contrast. After dry-
ing, the grids were then viewed on Philips CM 10 TEM.
For negative controls, the primary antibody was replaced
by the pre-immune serum.
Capture of invasive merozoites
Plasmodium falciparum 3D7 parasite was cultured and syn-
chronized as described above and allowed to grow for one
cycle before the onset of the experiment. Parasites in the
second cycle were grown to the late schizont stage and
parasite thin slides were prepared every 30 min over a 4 h
window (estimated time of invasion ± 2 h). Slides repre-
senting the invasion process, as assessed by Giemsa stain-
ing for merozoite attachment to erythrocyte surfaces, were
analysed in IFA using anti-PFL2610w antibody as a repre-
sentative anti-STEVOR antibody.
Antibody invasion inhibition assay
Serum and Protein G-purified total IgG generated against
the PFL2610w STEVOR variant and from a naïve mouse
were used in the inhibition assays. Anti-MSP1 antiserum
served as a positive control. The invasion inhibition assays
were performed in duplicates one cycle after synchroniza-
tion by inoculation of fresh erythrocytes with IE (at 0.5%
parasitaemia and 2% haematocrit) in a 100 μl volume in
96-well flat-bottomed tissue culture plates [17]. Wells
with only uninfected cells served as blanks, those with
both infected and uninfected but no antibodies as con-
trols. Sera constituted 1, 3 or 10% of the total assay vol-
ume. Either serum or purified IgG samples (at final
concentrations of 0.1, 0.3 or 1 mg/ml) were added at assay
set up, prior to reinvasion. Parasites and antibodies were
incubated for 24 h, thereafter [3H]hypoxanthine (GE
Healthcare, Life Sciences, Bucks, UK) was added (1 μCi/
well). After 16 h, cells were harvested onto glass filters and
incorporated radioactivity determined as counts per
minute (cpm). Calculations were made using the formula:
Results
Antigenic variation and parasite phenotype
Multiple stevor transcripts in a given parasite population
have previously been identified [18]. Synthesis in a single
cell of 2 to 3 copies of full-length transcripts has also been
reported [19]. To date it is unknown whether multiple ste-
vor transcripts are correlated with the expression of multi-
ple STEVOR proteins. Evidence for clonal variation and
gene switching in stevor genes transcription was recently
described [20]; however, occurrence of antigenic variation
at the protein level is still lacking. By analogy with specific
var gene expression being related to distinct binding phe-
notypes, we questioned if such a phenomenon existed for
STEVORs. To follow changes in STEVOR expression, two
different parasite lines NF54CD36 and NF54CSA, each with
binding phenotypes specific for either CD36 or CSA,
respectively were used. The CD36 selected line was
expected to represent a set of multiple clones (popula-
tion), at least in vitro in the absence of immune pressure.
%
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However, we believe that each one was capable of CD36
binding, based on the knowledge that there is no a strict
link of this phenotype to a single var gene, unlike the CSA-
binding phenotype for which the var2CSA gene is respon-
sible. Parasite lines NF54CD36-R and NF54CSA-R, following
loss of their original binding phenotypes through subse-
quent rounds of culture under no selection pressure were
included. Anti-STEVOR antibodies generated against four
different STEVOR variants, whose genes were cloned from
the P. falciparum 3D7 parasite were available for study
[21]. Each of these four antibodies recognized the corre-
sponding recombinant protein and the other three pro-
teins indicating that the individual antibody cross reacts
with other STEVOR proteins (data not shown). Presuma-
bly the cross reactivity is due to the common conserved
domains carried on the recombinant proteins. Cross reac-
tivity with uninfected erythrocyte proteins or members of
a closely related protein family such as that of the RIFIN
family was ruled out by immunoblot analyses using total
lysates prepared from uninfected erythrocytes or an array
of representative recombinant RIFIN proteins [22,23].
Upon analysis of the differentially selected parasite lines
in immunoblots, considerable differences in band inten-
sities (taken as a measure of the expression level of STE-
VOR variants) were observed compared to the parent
parasite NF54. Using the anti-PFL2610w antibody to
probe the lysed IE, three different STEVOR variants with
molecular masses of 28, 32 and 40 kDa in the unselected
parent line NF54 were observed, the 32 kDa variant being
the most abundant (Figure 1A, lane 1). After selection for
CD36 binding, the 28 kDa variant in NF54CD36 almost
disappeared while the 32 kDa variant showed reduced
band intensities, in contrast the 40 kDa band which
increased in intensity (lane 2). After loss of CD36 binding,
a different level of STEVOR expression was observed,
whereby all 3 STEVOR variants reappeared in intensities
different from both NF54 and NF54CD36 parasites (lane
3).
Similar changes in STEVOR expression profiles were
observed for the NF54CSA and the NF54CSA-R parasite lines.
Relative to the parent parasite NF54, the 28, 32 and 40
kDa variants were present in NF54CSA parasites, except
that the 32 kDa band was expressed at a lower level in the
parent line (lane 4). Loss of the CSA-binding phenotype
led to a dramatic decrease to an almost undetectable level
for the 28 and 40 kDa variants, whereas the expression
level of what appears to be the 32 kDa variant remained
(lane 5). No STEVORs were detected in uninfected eryth-
rocytes analysed in parallel (lane 6). Recognition of pro-
tein bands of different sizes and intensities was confirmed
with anti-PFC0025c, anti-MAL13P1.7 and anti-
PFA0750w antibodies (Figure 1B, C and 1D, respectively).
Detection of STEVOR proteins in merozoites
Anti-STEVOR peptide antibodies were used to demon-
strate its presence in MC in trophozoite- and schizont-IE
[24]. Other workers have localized STEVORs in the
plasma membrane of gametocyte-IE and in discrete foci
within the sporozoites [25]. In our IFA experiments, we
show perinuclear localization of STEVOR in the early
post-invasion ring stage using polyclonal anti-PFL2610w
STEVOR expression and parasite binding phenotype Figure 1
STEVOR expression and parasite binding phenotype. 
Immunoblots of parasite-IE extracts and human uninfected 
erythrocytes were probed for STEVOR variations using (A) 
anti-PFL2610w, (B) anti-PFC0025c, (C) anti-MAL13P1.7 or 
(D) anti-PFA0750w antibodies. Relevant molecular mass 
markers are shown.Malaria Journal 2008, 7:137 http://www.malariajournal.com/content/7/1/137
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antibody (Figure 2A). Late ring stage staining was evi-
denced by light punctuate fluorescence signals, in addi-
tion to a discrete rim staining associated with the IE
surface (Figure 2B). Trophozoite-IE gave a similar pattern,
but stronger overall staining was observed (Figure 2C).
Dual staining with anti-PfSBP1 antibodies confirmed STE-
VORs to be localized in MC (data not shown). The most
striking observation, never seen before, is the detection of
this multicopy gene family in merozoites (Figure 2D). To
complete the picture of stage specificity, fluorescence
staining performed in gametocytes revealed STEVOR pro-
teins internally, in the gametocyte membrane and also in
the IE membrane (Figure 2E).
Co-localization of STEVORs with the merozoite surface 
protein (MSP) 1
To verify the close association of STEVORs with the mero-
zoite surface, we performed co-localization studies with
STEVOR proteins in P. falciparum blood stage parasites Figure 2
STEVOR proteins in P. falciparum blood stage parasites. IFA images of parasite strain Gb337, cultured from a field iso-
late in (A) early ring, (B) ring, (C) trophozoite, (D) schizont and (E) gametocyte stages are visualized using anti-PFL2610w anti-
body. Bright field images (first column), parasite nuclei stained with DAPI (second column), STEVORs visualized with Alexa 488 
(third column) and overlay of nuclei and STEVOR protein staining (fourth column) are shown.Malaria Journal 2008, 7:137 http://www.malariajournal.com/content/7/1/137
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antibodies to MSP-1. The IFA experiments revealed a strict
co-localization of STEVORs with MSP-1 in developing
schizonts (Figure 3A) as well as in a ruptured schizont
(Figure 3B), representatively shown for anti-PFL2610w
antibodies. In addition to the surface fluorescence, anti-
STEVOR antibody was seen to consistently and strongly
stain a spot within the merozoite at the apical end, oppo-
site of the nucleus. Further experiments to exclude the
possibility that surface staining is due to membrane frag-
ments arising from a rupturing schizont, naturally
released free merozoites were prepared and stained with
anti-STEVOR antibodies (Figure 3C and 3D). Fluores-
cence staining of both the surface of the merozoite as well
as the additional spotted apical staining cap was evident.
Overall, staining was strongest at the apical end, possibly
reflecting greater abundance of STEVOR in this region of
the merozoite.
Location of STEVORs by immunoelectron microscopy 
(IEM)
To extend the IFA data, IEM was performed using anti-
PFL2610w antibody. For the first time, gold particles were
observed on the erythrocyte surface, associated both with
electron dense knobs and the membrane bilayer (Figure
4A, C and 4D). Equally significant was the clear labelling
in the electron-dense rhoptry organelles of the parasite
(Figure 4A), sometimes specifically localized to the neck
of the rhoptries (Figure 4E–H). Coherent staining on the
surface of developing merozoites was evident (Figure 4A)
as was the consistent labelling of MC (Figure 4A, C and
4D). No reactivity was seen with pre-immune serum (Fig-
ure 4B).
In general, a low density of gold particles was a character-
istic on the IEM sections and this could be attributed to
the high dilution of the antibody (1:10,000) used in the
experiments or to the paucity of STEVOR proteins on the
IEM sections.
Implication of STEVORs in merozoite invasion
Here, IFA evidence for STEVOR protein expression in the
merozoite was provided and their presence both on the
surface and apically in the rhoptry were specifically shown
in IEM. Prompted by these findings and based on knowl-
Co-localization of STEVOR proteins with MSP-1 Figure 3
Co-localization of STEVOR proteins with MSP-1. Fluorescence staining using anti-PFL2610w and anti-MSP-1 antibodies 
was analysed in (A) a P. falciparum schizont, (B) a ruptured schizont and (C and D) free merozoites. Bright field images (left col-
umn), DAPI stained parasite nuclei (second column), Alexa 488 stained MSP-1 (third column), Alexa 594 stained STEVOR pro-
teins (fourth column) and the overlay of nuclei, MSP-1 and STEVOR proteins (fifth column) are shown.Malaria Journal 2008, 7:137 http://www.malariajournal.com/content/7/1/137
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edge that invasion is completed within ~30 seconds after
merozoite release from schizonts, a role of STEVORs in
the invasion process was explored.
Slides representing invasion at progressive steps showed
the presence of proteins from a variant multigene family
in invading merozoites. In addition to surface staining of
free merozoites with an apical focus (Figure 5A), we
observe STEVOR labelling of a merozoite "docking" onto
the erythrocyte surface (Figure 5B). Notably, STEVOR pro-
teins were not only confined to the merozoite, but were
also evident in association with a comet-like structure
emanating from the invading merozoite (highlighted by
ellipses) (Figure 5C and 5D). Whether STEVORs are being
cleaved or are simply released together with other proteins
involved invasion such as MSP-1 and AMA-1 remains to
Immunoelectron microscopic localization of STEVORs Figure 4
Immunoelectron microscopic localization of STEVORs. Ultrathin sections of schizont stage-IE were analysed using 
anti-PFL2610w antibody. Gold labelling is observed on the IE surface (A and C, black arrowheads), merozoite surface (A, black 
arrows), in MC (A, C and D, white arrowheads), rhoptries (A, white arrows) and rhoptry neck (E-H, white arrows). No gold 
particles are observed with pre-immune serum, shown for an IE containing developing merozoites (B). Scale bars are 0.5 μm 
for A and 1 μm for B-H.Malaria Journal 2008, 7:137 http://www.malariajournal.com/content/7/1/137
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be studied. In subsequent steps involving invagination
and entry, STEVORs continue to be present (Figure 5E and
5F, respectively).
No inhibition of invasion by anti-STEVOR antibodies
Prompted by the above observations, whether anti-STE-
VOR antibodies can block the erythrocyte invasion proc-
ess was investigated. Anti-MSP-1 antiserum yielded 100%
invasion inhibition when used at its maximal concentra-
tion (10%) in the assay. The same anti-PFL2610w antise-
rum concentration inhibited invasion by 54%, while pre-
immune serum yielded a 46% inhibition (Figure 6). This
finding suggests a non-specific interference of the sera
with invasion. Despite the use of purified IgG fractions
(up to 1 mg/ml), no significant adverse effects on mero-
zoite invasion were observed. At this concentration, 36%
invasion inhibition was observed with the test IgG sam-
ple, compared to 25% with pre-immune IgG.
Discussion
In the asexual life cycle of the P. falciparum parasite, mero-
zoites use different categories of proteins that function
STEVOR reactivity in merozoite invasion Figure 5
STEVOR reactivity in merozoite invasion. STEVORs are localized on merozoites (A) in free form, (B) docking, (C and D) 
invading, (E) invaginating and (F) entering an erythrocyte. Enlarged images (G and H) show staining of comet-like structures. 
White arrows and arrowheads indicate STEVORs on the merozoite surface and apex, respectively. White circles and ellipses 
highlight the invasive merozoite and the comet, respectively. Bright field images (first column), STEVOR proteins visualized 
with green Alexa 594 (second column), merozoite nuclei stained with blue DAPI (third column), overlay of STEVOR protein 
staining and nuclei (fourth column) and the overlay of bright field, STEVOR protein staining and nuclei (fifth column) are shown.Malaria Journal 2008, 7:137 http://www.malariajournal.com/content/7/1/137
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both intracellularly and extracellularly to invade new
erythrocytes within 30 sec after their release from sch-
izonts. Once inside, they develop within the parasitopho-
rous vacuole (PV) and begin to export proteins to the
erythrocyte cytoplasm and membrane, thereby modifying
it. Exported proteins with structural functions are encoded
by single copy genes, whose sequences hardly vary, such
as KAHRP, MESA, PfEMP3 (reviewed in [26]) and PfSBP1
[27]. Those encoded by multigene families, such as
PfEMP1, RIFIN and STEVOR carry hypervariable
domains, which may have crucial roles in parasite sur-
vival.
Hypervariability in the coding sequence of STEVORs sug-
gests that they undergo antigenic variation, even though
data at the protein level are still lacking. In a study
designed to assess gene transcription patterns in selected
versus unselected 3D7 parasite populations by real time
PCR [28], no change in the transcription pattern of stevor
genes due to selection was observed, i.e. an erythrocyte
population able to bind trHBMEC cell lines transcribes
the same stevors at similar levels to those cells unable to
bind. Another study using the limiting dilution method to
create different NF54 parasite clones or populations
showed that stevor transcription was clonally variant [29].
Here, evidence of antigenic variation in STEVORs at the
protein level was presented, as seen by differences in levels
of detected STEVOR proteins as well as presence or
absence of one or more variants upon selection for a phe-
notype or loss of a phenotype. Such differences between
unselected, selected and lost phenotype lines most proba-
bly reflect differences in parasite populations responsible
for the expression of distinct STEVOR variants. In other
words, selection of a binding phenotype seemed to be
accompanied by an enrichment of major parasite popula-
tion (s), their relative abundance to each other vary
according to the major phenotype the parasite line repre-
sent. Accordingly, similar band patterns seen in Figure 1
were expected in both selected and unselected parasite
line but dramatic changes in the expression level of STE-
VOR were observed upon selection. A loss of binding is
also most likely to be accompanied by similar changes.
Here, the antibodies not only recognized different STE-
VOR subtypes in different parasites but also identified
STEVOR variants with different expression levels, subse-
quent to changes in their binding phenotypes. This
expression data are discrepant with work by the former
group but complement that of the latter group. The dis-
crepancy could be attributed to the use of different para-
site strains or to post-transcriptional control mechanisms
leading to the selection of a distinct transcript for protein
expression, and not another.
Earlier attempts to localize STEVORs in developing mero-
zoites of P. falciparum schizonts using an anti-STEVOR
peptide antibody failed [30], presumably because of low
detection limits. The demonstration of STEVORs on the
merozoite membrane was confirmed using an anti-MSP-1
antibody. Furthermore, IEM studies located the protein to
the erythrocyte membrane, as expressed also by an
epitope-tagged STEVOR in a transgenic NF54 parasite line
[31]. STEVORs were additionally found in membranous
structures in the erythrocyte cytosol. Many of these were
in close vicinity to the surface membrane, which brings to
mind the picture that these molecules are en route to the
erythrocyte surface via the MC. Finally, fine mapping of
STEVORs to the rhoptries is novel and never seen before
for variant multigene family members. Examples of
smaller protein families undergoing limited polymor-
phisms in rhoptries are reticulocyte binding-like proteins
and RhopH1 encoded by the multicopy cytoadherence-
linked asexual gene family (reviewed in [32]), with sug-
gested or confirmed roles in host cell selection, binding,
antigenic variation, PV formation and rhoptry biogenesis.
The report of STEVORs in what looked like a discharged
merozoite coat is intriguing, opening up the possibility
that STEVORs may play an important role in erythrocyte
invasion. STEVORs could assist adhesion to the erythro-
cytes and/or protect the free merozoites from immune
attack and could have also a supportive role in the release
or cleavage of membranous structures from the mero-
zoite. It is unlikely that the comet tail-like structures are an
artefact caused by "smearing" of merozoite surface pro-
teins during thin film preparation, since such structures
Inhibition of erythrocyte invasion by P. falciparum merozoites Figure 6
Inhibition of erythrocyte invasion by P. falciparum 
merozoites. Varying concentrations of antibody as a per-
centage of the total assay volume were used, as shown for 
anti-PFL2610w (■), pre-immune serum () and anti-MSP-1 
antibody ( ▲ ).Malaria Journal 2008, 7:137 http://www.malariajournal.com/content/7/1/137
Page 10 of 11
(page number not for citation purposes)
are not seen around single "non-invading" merozoites,
and comets pointing in different directions have also been
observed on a same slide.
STEVORs remain associated with the merozoite during
invagination even when comet tails (at least those in
which STEVORs are present) are no longer detectable. This
is suggestive of a further role after invasion, and unproc-
essed or rudimentary STEVORs of merozoite origin would
explain the observed perinuclear IFA staining at early ring
stages.
The failure to show invasion inhibition by a single poly-
clonal anti-STEVOR antibody does not diminish the bio-
logical significance of STEVORs in the parasite nor its
vaccine candidacy. Conceivably, only antibodies gener-
ated against specific variants expressed in merozoites are
inhibitory. Also, invasion inhibition is more likely achiev-
able with monoclonal antibodies targetting crucial
epitopes on the variable domain. Moreover, growth inhi-
bition by purified human IgGs against putative vaccine
antigens are known to be effective in a cell-mediated but
not an antibody-dependent manner, exemplified by the
merozoite surface glutamate-rich protein [33]. Our dem-
onstration of STEVORs in the merozoite, particularly the
rhoptry and an association with invasion-related events
provides a foundation for speculating stevor  multigene
family members as potential vaccine target antigens
against the invasive forms of the P. falciparum life cycle.
Conclusion
The presence of STEVOR variants in the merozoite and its
secretory organelle, the rhoptry were demonstrated. They
appear to be associated with erythrocyte invasion events,
drawing the attention to an aspect of STEVOR function
that may be critical to parasite survival. It is conceivable
that these proteins encoded by the stevor multigene family
are involved in erythrocyte adhesion during invasion or in
assisting free merozoites to evade the host immune sys-
tem and to escape from several of its effector mechanisms.
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